Table 1.

Study inclusion and exclusion criteria.

Inclusion criteria	• Age ≥18 years
	• Diagnosed with cancer and assigned to receive a chemotherapeutic regimen containing at least one of the following agents:  - a platinum analogue, e.g. cisplatin, carboplatin, oxaliplatin  - a vinca alkaloid, e.g. vincristine  - a taxane, e.g. paclitaxel, docetaxel  - suramin  - thalidomide or lenalidomide  - bortezomib
	• Physical capability to follow the training programme implemented within the exercise intervention groups
Exclusion criteria	• Known peripheral neuropathy of any kind or any peripheral neuropathic signs or symptoms at baseline
	• Positive family history for any hereditary peripheral neuropathy
	• Known metastasis to the central or peripheral nervous system
	• Any physical or mental handicap that would hamper the performance of the training programme implemented within the exercise intervention groups
	• Known history of alcohol or illegal drug abuse or any constellation of lab values suggesting alcoholism, e.g. elevated GGT, MCV, CDT